3D Medicines, a tumor immunotherapy company, has recently completed the first round of financing after a US$140 million spin-off, which is approximately RMB970 million yuan. This round of financing was jointly led by eFung Capital and China Securities Jiantou Investment. Other investors including entrepreneur and investor Zheng Zhigang, as well as Ruiyi Investment, Tigermed, Shanghai […]
Immunotherapy Company 3D Medcines Raises Funds After Spin-Off comes from China Money Network: Primary Data for China's Primary Markets! All Rights Reserved.